<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01080781</url>
  </required_header>
  <id_info>
    <org_study_id>09 159 02</org_study_id>
    <nct_id>NCT01080781</nct_id>
  </id_info>
  <brief_title>Ephrin B1 Regulation in Human Right Appendage</brief_title>
  <acronym>REBORD</acronym>
  <official_title>Ephrin B1 Regulation in Human Right Appendage</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Background : Ephrin-B1 is part of the large Eph/Ephrin system which is involved in&#xD;
           cell-cell comunication. The role of Ephrin-B1 has scarcely been studied in adulthood.&#xD;
           Our team has shown that this protein is expressed in normal heart in mice and humans. In&#xD;
           mice with deletion of the gene encoding Ephrin-B1, we have shown progressive development&#xD;
           of dilated cardiomyopathy characterized by dramatic disorganization of cardiac tissue&#xD;
           architecture and decreased heart rate variability.&#xD;
&#xD;
        -  Purpose: Ephrin-B1 protein was recently identified in human heart but its putative role&#xD;
           remains unknown. In knockout mice, deletion of efn gene is associated with abnormalities&#xD;
           in cardiac architecture linked to defects in cell-cell tight junctions. From a&#xD;
           functional point of view, mice develop a dilated cardiomyopathy and exhibit decreased&#xD;
           heart rate variability in the frequency domain. The purpose of this study is to assess&#xD;
           if Ephrin-B1 expression is regulated in human heart and if expression level correlates&#xD;
           with heart rate variability.&#xD;
&#xD;
        -  Abstract: Thirty patients suffering from cardiac disease needing surgery will be&#xD;
           included and separated in two groups according to pressure levels in right auricle /and&#xD;
           or pulmonary artery. Ephrin-B1 expression will be assessed in right appendages at both&#xD;
           the transcriptional (quantitative PCR) and protein (Western blot) levels. Furthermore,&#xD;
           the putative relationship between Ephrin-B1 expression and heart rate variability (24&#xD;
           hours ECG recordings) will be investigated.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Outcomes&#xD;
&#xD;
        -  Primary: Expression level of gene encoding Ephrin B1 (quantitative PCR normalized&#xD;
           against GAPDH gene expression) on human right appendage biopsies&#xD;
&#xD;
        -  Secondary: a/ Expression level of Ephrin B1 protein on human right appendage using&#xD;
           Western blot and b/ Heart rate variability in both time and spectral domains&#xD;
&#xD;
        -  Study design: Exploratory, monocentric , prospective and comparative. Two groups of 15&#xD;
           patients each, age and sex matched, with or without elevated pressures in right auricles&#xD;
           or pulmonary arteries will be included.&#xD;
&#xD;
        -  Eligibility criteria:&#xD;
&#xD;
             -  Inclusion criteria: patients needing cardiac surgery and who had both right&#xD;
                catheterism and 24 hours ECG recording before inclusion; stable medications for at&#xD;
                least 4 weeks; age &gt; 18 years.&#xD;
&#xD;
             -  Exclusion criteria: Patient with pace-maker or atrial fibrillation&#xD;
&#xD;
        -  Number of subjects: 30 patients in two groups of 15 patients each.&#xD;
&#xD;
        -  Statistical analysis: Qualitative and quantitative variables will be compared using&#xD;
           McNemar test and t test respectively. A p value &lt; 0.05 will be considered as&#xD;
           significant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Expression level of gene encoding Ephrin-B1</measure>
    <time_frame>1 year</time_frame>
    <description>Expression level of gene encoding Ephrin-B1 (quantitative PCR normalized against GAPDH gene expression) on human right appendage biopsies</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Expression level of Ephrin B1 protein</measure>
    <time_frame>1year</time_frame>
    <description>Expression level of Ephrin B1 protein on human right appendage using Western blot and b/ Heart rate variability in both time and spectral domains</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Cardiac Diseases</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>normal pressures in right auricle (&lt;10 mmHg) /and or pulmonary artery (&lt;35 mmHg)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>high pressures in right auricle (&gt; 10 mmHg) /and or pulmonary artery (&gt;35 mmHg)</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      right appendage&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Cardiac diseases, right appendage&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients needing cardiac surgery and who had both right cardiac catheterism and 24&#xD;
             hours ECG recording before inclusion&#xD;
&#xD;
          -  Stable medications for at least 4 weeks&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with pace-maker or atrial fibrillation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Michel Senard, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Toulouse University Hospital</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <study_first_submitted>March 2, 2010</study_first_submitted>
  <study_first_submitted_qc>March 3, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2010</study_first_posted>
  <last_update_submitted>January 22, 2013</last_update_submitted>
  <last_update_submitted_qc>January 22, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 24, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiomyopathy</keyword>
  <keyword>Ephrin-B1 expression</keyword>
  <keyword>cell-cell junctions</keyword>
  <keyword>heart rate variability</keyword>
  <keyword>right appendage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

